Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs LUPIN - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES LUPIN ALKEM LABORATORIES/
LUPIN
 
P/E (TTM) x 37.5 40.7 92.1% View Chart
P/BV x 6.5 6.0 109.1% View Chart
Dividend Yield % 1.0 0.2 409.4%  

Financials

 ALKEM LABORATORIES   LUPIN
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-23
LUPIN
Mar-23
ALKEM LABORATORIES/
LUPIN
5-Yr Chart
Click to enlarge
High Rs3,625799 453.8%   
Low Rs2,835583 486.2%   
Sales per share (Unadj.) Rs970.1365.8 265.2%  
Earnings per share (Unadj.) Rs84.29.8 855.7%  
Cash flow per share (Unadj.) Rs110.229.2 377.3%  
Dividends per share (Unadj.) Rs50.004.00 1,250.0%  
Avg Dividend yield %1.50.6 267.4%  
Book value per share (Unadj.) Rs756.4270.7 279.5%  
Shares outstanding (eoy) m119.57454.98 26.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.31.9 176.3%   
Avg P/E ratio x38.470.2 54.6%  
P/CF ratio (eoy) x29.323.7 123.9%  
Price / Book Value ratio x4.32.6 167.3%  
Dividend payout %59.440.7 146.1%   
Avg Mkt Cap Rs m386,207314,381 122.8%   
No. of employees `000NANA-   
Total wages/salary Rs m21,31430,872 69.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m115,993166,417 69.7%  
Other income Rs m2,1611,509 143.2%   
Total revenues Rs m118,153167,926 70.4%   
Gross profit Rs m15,06517,206 87.6%  
Depreciation Rs m3,1048,807 35.2%   
Interest Rs m1,0742,743 39.1%   
Profit before tax Rs m13,0487,165 182.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,9802,688 110.8%   
Profit after tax Rs m10,0684,477 224.9%  
Gross profit margin %13.010.3 125.6%  
Effective tax rate %22.837.5 60.9%   
Net profit margin %8.72.7 322.7%  
BALANCE SHEET DATA
Current assets Rs m86,064124,513 69.1%   
Current liabilities Rs m37,07192,654 40.0%   
Net working cap to sales %42.219.1 220.6%  
Current ratio x2.31.3 172.8%  
Inventory Days Days3326 124.3%  
Debtors Days Days6798 68.3%  
Net fixed assets Rs m37,245103,490 36.0%   
Share capital Rs m239910 26.3%   
"Free" reserves Rs m90,208122,246 73.8%   
Net worth Rs m90,447123,156 73.4%   
Long term debt Rs m0275 0.0%   
Total assets Rs m124,541228,003 54.6%  
Interest coverage x13.23.6 364.1%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.90.7 127.6%   
Return on assets %8.93.2 282.5%  
Return on equity %11.13.6 306.2%  
Return on capital %15.68.0 194.5%  
Exports to sales %14.60-   
Imports to sales %00-   
Exports (fob) Rs m16,916NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m16,91648,057 35.2%   
Fx outflow Rs m4,19021,752 19.3%   
Net fx Rs m12,72726,306 48.4%   
CASH FLOW
From Operations Rs m16,82518,972 88.7%  
From Investments Rs m1,128-12,868 -8.8%  
From Financial Activity Rs m-17,608-3,373 522.1%  
Net Cashflow Rs m4162,732 15.2%  

Share Holding

Indian Promoters % 56.7 46.8 121.3%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 24.4 45.8 53.2%  
FIIs % 8.5 16.1 52.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 43.3 53.0 81.7%  
Shareholders   65,184 281,542 23.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   SUN PHARMA    CIPLA    DIVIS LABORATORIES    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on ALKEM LABORATORIES vs Lupin

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ALKEM LABORATORIES vs Lupin Share Price Performance

Period ALKEM LABORATORIES Lupin S&P BSE HEALTHCARE
1-Day -1.18% 1.23% 1.18%
1-Month -0.99% 0.15% -0.75%
1-Year 52.26% 151.14% 61.82%
3-Year CAGR 21.70% 17.13% 18.16%
5-Year CAGR 22.99% 17.42% 19.79%

* Compound Annual Growth Rate

Here are more details on the ALKEM LABORATORIES share price and the Lupin share price.

Moving on to shareholding structures...

The promoters of ALKEM LABORATORIES hold a 56.7% stake in the company. In case of Lupin the stake stands at 47.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALKEM LABORATORIES and the shareholding pattern of Lupin.

Finally, a word on dividends...

In the most recent financial year, ALKEM LABORATORIES paid a dividend of Rs 50.0 per share. This amounted to a Dividend Payout ratio of 59.4%.

Lupin paid Rs 4.0, and its dividend payout ratio stood at 40.7%.

You may visit here to review the dividend history of ALKEM LABORATORIES, and the dividend history of Lupin.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.